tiprankstipranks
Trending News
More News >
Rising Biosciences Inc (RBII)
OTHER OTC:RBII
US Market

Rising Biosciences (RBII) Ratios

Compare
20 Followers

Rising Biosciences Ratios

See a summary of RBII’s cash flow.
Ratios
Dec 20Dec 19
Liquidity Ratios
Current Ratio
0.12
Quick Ratio
0.10
Cash Ratio
0.03
Solvency Ratio
0.05
Operating Cash Flow Ratio
-0.04
Short-Term Operating Cash Flow Coverage
-0.07
Net Current Asset Value
$ ―$ -1.52M
Leverage Ratios
Debt-to-Assets Ratio
1.65
Debt-to-Equity Ratio
-0.97
Debt-to-Capital Ratio
-31.66
Long-Term Debt-to-Capital Ratio
0.00
Financial Leverage Ratio
-0.59
Debt Service Coverage Ratio
0.14
Interest Coverage Ratio
4.09
Debt to Market Cap
0.83
Interest Debt Per Share
<0.01
Net Debt to EBITDA
6.60
Profitability Margins
Gross Profit Margin
57.32%
EBIT Margin
15.23%
EBITDA Margin
19.52%
Operating Profit Margin
36.33%
Pretax Profit Margin
6.36%
Net Profit Margin
6.36%
Continuous Operations Profit Margin
6.36%
Net Income Per EBT
100.00%
EBT Per EBIT
17.51%
Return on Assets (ROA)
7.77%
Return on Equity (ROE)
-4.57%
Return on Capital Employed (ROCE)
-26.08%
Return on Invested Capital (ROIC)
-851.70%
Return on Tangible Assets
7.77%
Earnings Yield
3.91%
Efficiency Ratios
Receivables Turnover
6.46
Payables Turnover
6.87
Inventory Turnover
8.45
Fixed Asset Turnover
2.85
Asset Turnover
1.22
Working Capital Turnover Ratio
-0.51
Cash Conversion Cycle
46.54
Days of Sales Outstanding
56.48
Days of Inventory Outstanding
43.21
Days of Payables Outstanding
53.15
Operating Cycle
99.69
Cash Flow Ratios
Operating Cash Flow Per Share
>-0.01
Free Cash Flow Per Share
>-0.01
CapEx Per Share
0.00
Free Cash Flow to Operating Cash Flow
1.00
Dividend Paid and CapEx Coverage Ratio
0.00
Capital Expenditure Coverage Ratio
0.00
Operating Cash Flow Coverage Ratio
-0.07
Operating Cash Flow to Sales Ratio
-0.09
Free Cash Flow Yield
-5.53%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
25.56
Price-to-Sales (P/S) Ratio
1.63
Price-to-Book (P/B) Ratio
-1.17
Price-to-Free Cash Flow (P/FCF) Ratio
-18.08
Price-to-Operating Cash Flow Ratio
-18.08
Price-to-Earnings Growth (PEG) Ratio
-0.26
Price-to-Fair Value
-1.17
Enterprise Value Multiple
14.93
Enterprise Value
2.28M
EV to EBITDA
14.93
EV to Sales
2.91
EV to Free Cash Flow
-32.41
EV to Operating Cash Flow
-32.41
Tangible Book Value Per Share
>-0.01
Shareholders’ Equity Per Share
>-0.01
Tax and Other Ratios
Effective Tax Rate
<0.01
Revenue Per Share
<0.01
Net Income Per Share
<0.01
Tax Burden
1.00
Interest Burden
0.42
Research & Development to Revenue
0.00
SG&A to Revenue
0.00
Stock-Based Compensation to Revenue
0.00
Income Quality
-1.41
Currency in USD